To Market, To Market-2006

被引：15

作者：

Hegde, Shridhar ^{[1
]}

Schmidt, Michelle ^{[1
]}

机构：

[1] Pfizer Inc, St Louis, MO 63017 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42 | 2007年 / 42卷

关键词：

D O I：

10.1016/S0065-7743(07)42032-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：505 / 554

页数：50

共 136 条

[1] Rheumatoid arthritis: developing pharmacological therapies [J].

Abbott, JD ;

Moreland, LW .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (08) :1007-1018

[2]

ABRAMOWICZ M, 2006, MED LETT DRUGS THER, V48, P74

[3]

ABRAMOWICZ M, 2007, MED LETT DRUGS LETT, V49, P6

[4] Ranolazine [J].

Abrams, Jonathan ;

Jones, Carole A. ;

Kirkpatrick, Peter .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :453-+

[5] Nimotuzumab: Evidence of clinical benefit without rash [J].

Allan, DGP .

ONCOLOGIST, 2005, 10 (09) :760-761

[6]

Arthur F. K., 1986, US Pat, Patent No. [4,567,264, 4567264]

[7] Posaconazole [J].

Ashley, ESD ;

Alexander, BD .

DRUGS OF TODAY, 2005, 41 (06) :393-400

[8] The role of decitabine in the treatment of myelodysplastic syndromes [J].

Atallah, Ehab ;

Kantarjian, Hagop ;

Garcia-Manero, Guillermo .

EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (01) :65-73

[9] Sunitinib maleate [J].

Atkins, M ;

Jones, CA ;

Kirkpatrick, P .

NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (04) :279-280

[10] Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertension [J].

Barst, Robyn J. .

EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (01) :95-109

← 1 2 3 4 5 6 7 8 9 10 →